Prof. Alex Levitzki developed new drugs to fight cancer

Prof. Alex Levitzky recently published a study in the journal "Oncogene" describing activity of the molecule NT157  against metastatic melanoma.
In an accompanying article in the same journal, the results of another study, conducted by Prof. Levitzky in collaboration with Prof. Michael Karin of the University of California, San Diego, show the dramatic therapeutic effects of NT157 in colon cancer of mice.
Oncogene paper describing effects on melanoma
Oncogene paper describing effects on colon cancer